You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
天士力(600535.SH):子公司完成協議轉讓I-MAB 0.34%的非流通普通股
格隆匯 11-19 18:12

格隆匯11月19日丨天士力(600535.SH)公佈,公司控股子公司天士力生物醫藥股份有限公司(“天士力生物”)的全資子公司天士力生物科技有限公司(“天士力生物科技”)通過非公開協議轉讓方式向Huatai Capital Investment Limited(華泰資本投資有限公司,“華泰資本”)轉讓所持I-MAB(NASDAQ:IMAB)的部分非流通普通股。

天士力生物科技與華泰資本於2021年10月20日簽署了《股份轉讓協議》,天士力生物科技將持有的佔I-MAB總股數0.34%的非流通普通股轉讓給華泰資本,交易對價為1600.02萬美元。

截至本公吿日,天士力生物已收到交易對方的本次股份轉讓價款,目前已完成股份交割手續。

本次向華泰資本轉讓股權後,按照截至2021年9月30日IMAB不含股權激勵的口徑,公司對I-MAB持股比例將減少至5.64%(按照IMAB包含股權激勵的口徑,公司的持股比例減少至5.05%)。

通過與華泰資本的兩次交易,公司累計向華泰資本轉讓股數1,153,634股,扣除轉讓所對應的投資成本,按照最新人民幣兑美元匯率計算,公司實現投資收益摺合人民幣約1.7億元(具體數據以公司經審計財務數據為準)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account